Analysis of the cultured LMNs showed that in addition to maintaining ALS cellular markers, their survival rates mimicked ALS ...

The data shows that RNA interacts with a mitochondrial protein complex to trigger immune response pathways when viral RNA is ...

The company is launching a Phase Ib study that will test its first gene therapy in patients with locally advanced rectal ...

Through its collaboration with Nvidia, Genesis is working to accelerate development of its AI platform, Genesis Exploration ...

GEN presents data compiled by Morningstar's Morningstar Direct asset management platform for StockWatch of the top five ...

Novel vaccine platform improved protection against diverse influenza subtypes when tested in animal models and human organoids.

The newly reported study showed that impaired regulatory T cells are a critical contributing factor to Sjögren’s disease in ...

The U.S. CDMO recently signed its first contract with a customer, Serpin Pharma, to support their clinical manufacturing.

The tested model identified the best and least good variants and had a 74% overlap with real-life data on the average ...

Despite being positive about DNA-based vaccine production in general, the study did identify areas in need of better ...

Research reveals how the body clock regulates inflammation and highlights mitochondria's role in driving daily changes in ...

Results identify intestinal epithelial 5-HT as a new and potentially safer therapeutic target for mood regulation.